Core Insights - Homeland Uranium Corp. has provided an update on the Phase II exploration drilling program at the Coyote Basin Uranium Project, indicating progress in understanding the mineralized horizon [1][5]. Drilling Program Update - Six additional Reverse Circulation (RC) drillholes (CB-RC-0029 to CB-RC-0034) have been completed, totaling approximately 5,300 meters (17,500 feet) [2]. - The new drillholes were spaced 200 meters (656 feet) apart and located 200 meters (656 feet) south of previously reported sections [2]. - The results from these drillholes confirm the southward continuity of an anomalously radioactive horizon over an interpreted strike length of approximately 200 meters (656 feet) [4]. Geological Findings - Anomalous radioactivity has been defined over an area of approximately 1,000 meters (3,280 feet) by 200 meters (656 feet), remaining open for expansion in all directions [4]. - The dip and geometry of the radiometric response are consistent with those identified in earlier drilling, indicating a laterally extensive mineralized horizon [5]. Future Plans - The company plans to test a third fence of drillholes approximately 200 meters (656 feet) south of the newly drilled section [5]. - Geochemical samples from the completed drillholes have been sent to SGS Laboratories for analysis, with results expected to be reported after review [6]. Quality Assurance Measures - All drillholes are logged using a calibrated QL40 SGR Spectral Gamma Ray downhole probe to collect continuous spectral gamma measurements [8]. - The company has collected samples from each 5-foot interval for geochemical analysis, ensuring adherence to quality standards [11]. Historical Resource Context - The Coyote Basin Project is reported to contain an estimated historical resource of 8,850,000 tons grading 0.20% U3O8, totaling 35.4 million pounds of U3O8 [14].

NEW YORK, Dec. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Integer Holdings Corporation (NYSE: ITGR). Shareholders who purchased shares of ITGR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/integer-holdings-corporation-loss-submission-form/?id=180989&from=4 CLASS ...

NEW YORK, Dec. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). Shareholders who purchased shares of TLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/telix-pharmaceuticals-ltd-loss-submission-form/?id=180979&from=4 CLASS PERIO ...

NEW YORK, Dec. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of James Hardie Industries plc. (NYSE: JHX). Shareholders who purchased shares of JHX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/james-hardie-industries-plc-loss-submission-form/?id=180973&from=4 CLASS PER ...

PHILADELPHIA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ: DVLT), a pioneer in AI-driven data valuation, monetization, and quantum-encrypted RWA tokenization, today announced the issuance of two key U.S. patents that significantly bolster its intellectual property portfolio in blockchain-based content management and monetization. The newly issued patents cover groundbreaking systems and methods for secure content licensing and tokenized monetizati ...

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Aegis Critical Energy Defence Corp. (CSE: QESS) (OTCQB: QESSF) (FSE: JG6) ("Aegis" or the "Company") announces that it has entered into a legally binding agreement with Seetel New Energy Co. Ltd. (Taiwan) (7740.TW) through the formation of Cordelia BESS Inc., an Ontario-incorporated project company established for the purpose of participating in Ontario's grid-scale energy storage market.Cordelia BESS Inc. has submitted a proposal Thursday ...

Core Insights - Novo Nordisk's stock has significantly declined, losing over two-thirds of its value since mid-2024, despite initial excitement over its GLP-1 weight loss drugs [1] - Eli Lilly's weight loss drug tirzepatide has outperformed Novo Nordisk, with Zepbound sales increasing by 185% year over year in Q3, while Novo Nordisk reported only 12% sales growth in its obesity treatment and diabetes care operations [3] - Pfizer is making aggressive moves to re-enter the GLP-1 market, indicating a potential investment opportunity as it seeks to recover from recent pressures [4][7] Industry Dynamics - The pharmaceutical industry faces challenges in developing new drug candidates, which is a costly and complex process [1] - Being first to market does not guarantee success, as differences in drug effects, costs, and outcomes can significantly impact market performance [2] - Eli Lilly currently holds the leading position in the GLP-1 weight loss space, demonstrating that early leadership does not ensure sustained market dominance [6]

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. UnitedHealth has pledged to make a range of improvements in response to the first outside reviews of its business practices as the healthcare behemoth works to improve waning consumer trust. The independent analyses, completed by FTI Consulting and the Analysis Group in November and released on Friday, didn’t find a smoking gun that UnitedHealth is leveraging ...

This story was originally published on C-Store Dive. To receive daily news and insights, subscribe to our free daily C-Store Dive newsletter. Performance Food Group has promoted president and chief operating officer Scott McPherson to CEO, effective Jan. 1, 2026, the foodservice distribution giant announced last week. McPherson, who will also join PFG’s board of directors, will succeed George Holm, who is transitioning to executive chair of the board. Holm will continue to work with McPherson on M&A activ ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Dive Brief: Aktis Oncology has become the first biotechnology company to file for an initial public offering in several weeks, outlining on Friday a stock issuance to help advance a pipeline of radiopharmaceuticals for cancer. Aktis specializes in what it calls “miniprotein radioconjugates,” which it believes to be capable of accessing tumor targets that are ...